|
Wednesday, May 28, 2008
Abraxis BioScience Names CFO
Los Angeles-based Abraxis BioScience said today that it has named David O'Toole as the firm's Executive Vice President and Chief Financial Officer. O'Toole joins the firm from Deloitte & Touche LLP, where he was a Partner in the firm's Strategic Client Group. O'Toole has served at Deloitte for the past 16 years. Abraxis said that it's current CFO, Lisa Gopala, has resigned to join a philanthropic venture fund. Abraxis BioScience is a biopharmaceuticals development firm.
posted on Wednesday, May 28, 2008
|
 RSS
 Email
Twitter
Previous news:
Monday, July 6, 2009
Thursday, July 2, 2009
Wednesday, July 1, 2009
Tuesday, June 30, 2009
Monday, June 29, 2009
|
